-
Int J Clin Pharm Th · Sep 2012
CommentComment on the report "limitations of model-based dose selection for indacaterol in patients with chronic obstructive pulmonary disease".
- Michael Looby, Didier Renard, Andrew Wright, David Morris, and Donald Stanski.
- Novartis Pharma AG, Basel, Switzerland. Michael.Looby@Novartis.com
- Int J Clin Pharm Th. 2012 Sep 1; 50 (9): 631-7; discussion 638.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..